Sponsors

Hepatitis C virus immunoassay

Roche Diagnostics has announced that the Elecsys anti-hepatitis C virus (HCV) assay has received regulatory approval in Europe for the E170 analyser for modular analytics and the e601 module for the Cobas 6000 platform. The Elecsys anti-HCV assay is already available on the Elecsys 2010 and the Cobas e411 instruments.

Hepatitis C virus infection represents a major cause of death through the development of severe fibrosis, cirrhosis and liver cancer. The principal mode of transmission is parenteral exposure to infected blood or blood products (ie insufficient blood screening procedures, mainly in developing countries) and contaminated needles or other invasive medical tools.

Roche
www.roche.com

Latest Issues

UKHSA Conference 2026

Manchester Central, Manchester, M2 3GX
22-23 September, 2026

Cardiac Marker Dialogues

Technology and Innovation Centre, University of Strathclyde, 99 George Street, Glasgow, G1 1RD
24-25 September, 2026

46th European Congress of Cytology

Hilton Antwerp Old Town, Antwerp
4-7 October, 2026

Introduction to Cellular Components, Tissue Morphology and Tissue Recognition Master Class

The Haylofts, St Thomas Street, Haymarket, Newcastle, NE1 4LE, UK
8 October, 2026